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FIGURE 1. Insertion of pledgeted sutures for external left ventricular plication.
Letters to the Editorstatement by Tibayan and associates4
gives supporting evidence for our hy-
pothesis. Other suggestions may also
provide alternative explanations for su-
periority of complete rings relative to
partial ones.
As Kwon and colleagues1
mentioned, although complete rings
are better for the treatment of func-
tional mitral regurgitation, they need
further advances in multiple aspects
to be considered as the best treatment
option, because recurrence rates are
still high. We think that the complete
rings are quite well in fixing septolat-
eral dimension changes at the annular
level; however, they are not adequate
for fixing septolateral dimension
changes at the equatorial level of the
left ventricle. That is why increased
preoperative left ventricular dimen-
sion with a left ventricular end-
diastolic diameter greater than 65
mm is the most accepted preoperative
risk factor for higher rate of recur-
rence after ring annuloplasty in func-
tional mitral regurgitation, as Kwon
and colleagues1 mentioned in their
article.
We believe that brainstorming
regarding the underlying mechanism
of recurrence will improve our knowl-
edge and understanding of functional
mitral regurgitation.
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To the Editor:
We congratulate Michler and col-
leagues1 on their successful surgery
and excellent study recently reported
online in the Journal. We would also
like to highlight some issues.
In the article’s Figure E4, A,1 there
was no reduction in left ventricular
end-systolic volume index (LVESVI)Cardiovascular Surgery c November 20in patients undergoing coronary bypass
grafting (CABG), and left ventricular
ejection fraction did not increase either
(as seen in the article’s Table 21).
Nevertheless, left ventricular ejection
fraction did increase significantly in
patients with CABG plus surgical ven-
tricular reconstruction (SVR), and we
therefore propose that volume reduc-
tion is also necessary for the initial
CABG-only group.
In the article’s Figure E4, B,1
LVESVI could be seen to drop as
low as 30 mL/m2 (normal volume) in
many patients undergoing CABG
plus SVR. So although ischemia was
relieved by CABG, some dilatation
may remain as a result of the continu-
ation of relative ischemia, according
to Laplace’s law. SVR should
therefore be expanded to include the
mitral annulus and ventricular base.
In addition, the existence of cases
with a LVESVI drop to 20 mL/m2 in
the article’s Figure E4, A,1 leads us
to think that an off-pump procedure
should be preferred.
Instead of left ventricular reduc-
tion,2 the insertion of papillary muscle
to the ventricular wall could be
palpated from outside on the beat-
ing heart, and the apex could be
plicated by inserting pledgeted sutures
anteroposteriorly and mediolaterally
at this level. The ventricular cavity
thus could be reduced near the base
externally (Figure 1).13
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IN THE POTENTIAL
INTERFERENCE ON
CARDIOPROTECTION BY
REMOTE ISCHEMIC
PRECONDITIONING:
b-BLOCKERS OR ANESTHETIC
CHOICE?
To the Editor:
We read with great interest the pa-
per from Kottenberg and colleagues,1TABLE 1. Results in metaregression and subgrou
Variables
No. of comparUnivariate analysis
b-blockers (%) (CABG only) 11
b-blockers (%) 14
Volatile agents 16
Multivariate analysis
b-blockers (%) 14
Volatile agents 14
Subgroup analysis
b-blockers (%) 14
>75% 5
75% 9
Volatile agents 15
Volatile 12
Nonvolatile 4
Original data from Zhou and associates.4 SMD, Standardize
The Journalrecently published online in the Jour-
nal. Building on their previous study,2
they have conducted 2 impressive
independent works to explore the car-
dioprotection by remote ischemic pre-
conditioning (RIPC) with isoflurane3
or propofol1 in coronary artery bypass
grafting (CABG).1-3
There has always been concern
regarding whether b-blockers could
interfere with the cardioprotective ef-
fect of RIPC. In their fundamental
study,2 the mean b-blocker usage rates
were 60% in the propofol substudy
and 64% in the isoflurane substudy,p analyses
isons
Coefficient or SMD
95%Coefficient
0.0258 0.0052 to
0.0161 0.0028–0
0.6617 0.0481 to
Coefficient
0.0129 0.00234 t
0.4037 0.5019 to
SMD
0.28 0.61 to
0.18 0.26 to
0.56 0.96 to
0.28 0.57 to
0.11 0.41 to
0.81 1.28 to
d mean difference; CI, confidence interval; CABG, coronary
of Thoracic and Cardiovascular Surgerand a better preservation of RIPC-
induced cardioprotection with isoflur-
ane than propofol was proposed. This
difference seems to remain unchanged
in the population, however, with
higher proportion of b-blocker medi-
cation (83% in propofol1 group and
87% in isoflurane).3 Their series of
studies indicates that the anesthetic
choice is more critical than b-blocker
use in the interference of cardiopro-
tection by RIPC.
Nevertheless, our group’s recent
meta-analysis,4 which included 15
randomized, controlled trials withCI P value
Adjusted R2 or
PDifference value
Adjusted R2
0.0567 .092 0.22
.0295 .022 0.37
1.3716 .065 0.23
Adjusted R2
o 0.0282 .089 0.38
1.3092 .348
PDifference value
0.04 .09 .02
0.61 .43
0.16 .006
0.02 .06 .01
0.19 .46
0.34 .0008
artery bypass grafting.
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